A comparison of Pembrolizumab plus Docetaxel versus placebo plus Docetaxel in patients with chemo-naive, metastatic prostate cancer.
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Highlands Ranch Hospital
University of Colorado Hospital
Thomas Flaig, MD
Protocol Number: 19-0473
More information available at ClinicalTrials.gov: NCT03834506
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers